A Vaccine Trial for Low Grade Gliomas
Phase 2
Recruiting
- Conditions
- Low Grade Glioma
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- James Felker
- Target Recruit Count
- 25
- Registration Number
- NCT02358187
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides with Imiquimod
Phase 1
Recruiting
- Conditions
- Ependymoma
- Interventions
- Biological: HLA-A2 restricted synthetic tumor antigenOther: enzyme-linked immunosorbent assayOther: flow cytometryOther: immunohistochemistry staining methodOther: laboratory biomarker analysis
- First Posted Date
- 2013-02-20
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- James Felker
- Target Recruit Count
- 24
- Registration Number
- NCT01795313
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas
Phase 1
Completed
- Conditions
- Newly Diagnosed Pediatric Pontine GliomaNewly Diagnosed Pediatric High Grade GliomaRecurrent Pediatric Low Grade GliomaRecurrent Pediatric High Grade Glioma
- Interventions
- Biological: HLA-A2 restricted glioma antigen peptides vaccine
- First Posted Date
- 2010-05-25
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- James Felker
- Target Recruit Count
- 60
- Registration Number
- NCT01130077
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath